Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Roche patents prodrugs of NMDA receptor antagonists

April 15, 2002

FDA concerns will delay Ariza marketing

April 15, 2002

GW expands phase III program for cannabis-based medicines

April 15, 2002

Enrollment completed in phase II/III trial of Neurodex for emotional lability

April 15, 2002

Preparation and use of NK1 receptor antagonists reported by Roche

April 12, 2002

New Agouron compounds and methods for treating beta-amyloid-mediated conditions

April 12, 2002

GABA-A receptor ligands specifically claimed for cognition disorders in recent patent

April 12, 2002

Study confirms equivalent efficacy for MT-100 and Imitrex in treatment of migraine

April 12, 2002

First patients enrolled in SAIK-MS phase II trial in multiple sclerosis

April 12, 2002

Approvable letter issued for Xyrem in cataplexy

April 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...